On the possible role of ERK, p38 and CaMKII in the regulation of CGRP expression in morphine-tolerant rats

Molecular Pain

Remi Quirion¹  Jean-Guy Chabot¹  Zhiyong Wang¹ 

[1]Dept. of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Quebec, H4H 1R3, Canada

关键词: morphine;    CaMKII;    p38;    ERK;    CGRP;   

Others  :  865773
DOI  :  10.1186/1744-8069-7-68

 received in 2011-04-01, accepted in 2011-09-21,  发布年份 2011

【 摘 要 】

Background

The neuropeptide, calcitonin gene-related peptide (CGRP) has been proposed to be a regulator of the development of morphine analgesic tolerance and thereby could be a target to reduce the induction of this phenomenon under clinical conditions. However, the mechanisms of CGRP regulation are unclear. We investigated here the possible role of the extracellular signal-regulated protein kinase (ERK), p38 and calcium/calmodulin-dependent protein kinase II (CaMKII) in CGRP regulation following chronic morphine treatment.

Results

A 7-day treatment with morphine (15 μg/day) led to an increase in CGRP contents in the spinal cord dorsal horn (SCDH) and dorsal root ganglion (DRG) and this effect was prevented by the inhibition of the ERK, p38 or CaMKII pathway. The phosphorylation/activation of ERK, p38 and CaMKII was enhanced in the SCDH following chronic morphine while in DRG only the phosphorylation of CaMKII was increased. Moreover, our chronic morphine treatment up-regulated neuronal nitric oxide synthase (nNOS) levels in the SCDH, an effect blocked by the inhibition of the ERK, p38 or CaMKII pathway. The blockade of nNOS activity also suppressed chronic morphine-induced CGRP increases in the DRG and SCDH. Double immunofluorescence studies revealed that nNOS and CaMKII are co-localized in the SCDH and that CaMKII is activated in CGRP-expressing DRG neurons.

Conclusions

The activation of spinal ERK, p38 and CaMKII, alongside nNOS, is involved in chronic morphine-induced CGRP up-regulation in both the DRG and SCDH. Moreover, the stimulation of CaMKII in the DRG likely directly regulates the expression of CGRP associated with morphine analgesic tolerance.

【 授权许可】

   
2011 Wang et al; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Foley KM: Misconceptions and controversies regarding the use of opioids in cancer pain. Anticancer Drugs 1995, 6(Suppl 3):4-13.
• [2]Rozenfeld R, Abul-Husn NS, Gomez I, Devi LA: An emerging role for the delta opioid receptor in the regulation of mu opioid receptor function. ScientificWorldJournal 2007, 7:64-73.
• [3]Menard DP, van Rossum D, Kar S, St Pierre S, Sutak M, Jhamandas K, Quirion R: A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. J Neurosci 1996, 16:2342-2351.
• [4]Powell KJ, Ma W, Sutak M, Doods H, Quirion R, Jhamandas K: Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br J Pharmacol 2000, 131:875-884.
• [5]Wang Z, Ma W, Chabot JG, Quirion R: Cell-type specific activation of p38 and ERK mediates calcitonin gene-related peptide involvement in tolerance to morphine-induced analgesia. FASEB J 2009, 23:2576-2586.
• [6]Wang Z, Ma W, Chabot JG, Quirion R: Calcitonin gene-related peptide as a regulator of neuronal CaMKII-CREB, microglial p38-NFkappaB and astroglial ERK-Stat1/3 cascades mediating the development of tolerance to morphine-induced analgesia. Pain 2010, 151:194-205.
• [7]Wang Z, Ma W, Chabot JG, Quirion R: Morphological evidence for the involvement of microglial p38 activation in CGRP-associated development of morphine antinociceptive tolerance. Peptides 2010, 31:2179-2184.
• [8]Gardell LR, Wang R, Burgess SE, Ossipov MH, Vanderah TW, Malan TP Jr, Lai J, Porreca F: Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers. J Neurosci 2002, 22:6747-6755.
• [9]Trang T, Ma W, Chabot JG, Quirion R, Jhamandas K: Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence. Pain 2006, 126:256-271.
• [10]Chung K, Lee WT, Carlton SM: The effects of dorsal rhizotomy and spinal cord isolation on calcitonin gene-related peptide-labeled terminals in the rat lumbar dorsal horn. Neurosci Lett 1988, 90:27-32.
• [11]Ai X, Cappuzzello J, Hall AK: Activin and bone morphogenetic proteins induce calcitonin gene-related peptide in embryonic sensory neurons in vitro. Mol Cell Neurosci 1999, 14:506-518.
• [12]Amann R, Sirinathsinghji DJ, Donnerer J, Liebmann I, Schuligoi R: Stimulation by nerve growth factor of neuropeptide synthesis in the adult rat in vivo: bilateral response to unilateral intraplantar injections. Neurosci Lett 1996, 203:171-174.
• [13]Cruise BA, Xu P, Hall AK: Wounds increase activin in skin and a vasoactive neuropeptide in sensory ganglia. Dev Biol 2004, 271:1-10.
• [14]Hall AK, Dinsio KJ, Cappuzzello J: Skin cell induction of calcitonin gene-related peptide in embryonic sensory neurons in vitro involves activin. Dev Biol 2001, 229:263-270.
• [15]Lindsay RM, Harmar AJ: Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989, 337:362-364.
• [16]Xu P, Van Slambrouck C, Berti-Mattera L, Hall AK: Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation. J Neurosci 2005, 25:9227-9235.
• [17]Xu P, Hall AK: Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons. Neuroscience 2007, 150:665-674.
• [18]Ma W, Zheng WH, Powell K, Jhamandas K, Quirion R: Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci 2001, 14:1091-1104.
• [19]Garry MG, Walton LP, Davis MA: Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from the spinal cord is mediated by nitric oxide but not by cyclic GMP. Brain Res 2000, 861:208-219.
• [20]Cridland RA, Henry JL: Effects of intrathecal administration of neuropeptides on a spinal nociceptive reflex in the rat: VIP, galanin, CGRP, TRH, somatostatin and angiotensin II. Neuropeptides 1988, 11:23-32.
• [21]Yu LC, Hansson P, Lundeberg T: The calcitonin gene-related peptide antagonist CGRP8-37 increases the latency to withdrawal responses in rats. Brain Res 1994, 653:223-230.
• [22]Poyner DR, Sexton PM, Marshall I, Smith DM, Quirion R, Born W, Muff R, Fischer JA, Foord SM: International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors. Pharmacol Rev 2002, 54:233-246.
• [23]Brain SD, Grant AD: Vascular actions of calcitonin gene-related peptide and adrenomedullin. Physiol Rev 2004, 84:903-934.
• [24]Simonetti M, Giniatullin R, Fabbretti E: Mechanisms mediating the enhanced gene transcription of P2X3 receptor by calcitonin gene-related peptide in trigeminal sensory neurons. J Biol Chem 2008, 283:18743-18752.
• [25]Chen Y, Yang C, Wang ZJ: Ca2+/calmodulin-dependent protein kinase II alpha is required for the initiation and maintenance of opioid-induced hyperalgesia. J Neurosci 2010, 30:38-46.
• [26]Cui Y, Chen Y, Zhi JL, Guo RX, Feng JQ, Chen PX: Activation of p38 mitogen-activated protein kinase in spinal microglia mediates morphine antinociceptive tolerance. Brain Res 2006, 1069:235-243.
• [27]Liang DY, Clark JD: Modulation of the NO/CO-cGMP signaling cascade during chronic morphine exposure in mice. Neurosci Lett 2004, 365:73-77.
• [28]Liu W, Wang CH, Cui Y, Mo LQ, Zhi JL, Sun SN, Wang YL, Yu HM, Zhao CM, Feng JQ, Chen PX: Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia. NeurosciLett 2006, 410:174-177.
• [29]Gibb BJ, Wykes V, Garthwaite J: Properties of NO-activated guanylyl cyclases expressed in cells. Br J Pharmacol 2003, 139:1032-1040.
• [30]Thippeswamy T, Haddley K, Corness JD, Howard MR, McKay JS, Beaucourt SM, Pope MD, Murphy D, Morris R, Hokfelt T, Quinn JP: NO-cGMP mediated galanin expression in NGF-deprived or axotomized sensory neurons. J Neurochem 2007, 100:790-801.
• [31]Riccio A, Alvania RS, Lonze BE, Ramanan N, Kim T, Huang Y, Dawson TM, Snyder SH, Ginty DD: A nitric oxide signaling pathway controls CREB-mediated gene expression in neurons. Mol Cell 2006, 21:283-294.
• [32]Chen Y, Geis C, Sommer C: Activation of TRPV1 contributes to morphine tolerance: involvement of the mitogen-activated protein kinase signaling pathway. J Neurosci 2008, 28:5836-5845.
• [33]Zhuang ZY, Gerner P, Woolf CJ, Ji RR: ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model. Pain 2005, 114:149-159.
• [34]Johnston IN, Milligan ED, Wieseler-Frank J, Frank MG, Zapata V, Campisi J, Langer S, Martin D, Green P, Fleshner M, et al.: A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J Neurosci 2004, 24:7353-7365.
• [35]Hargreaves K, Dubner R, Brown F, Flores C, Joris J: A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88.